Polar Asset Management Partners’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-71,980
Closed -$4.19M 692
2025
Q1
$4.19M Buy
+71,980
New +$4.91M 0.1% 203
2024
Q2
Sell
-50,302
Closed -$2.49M 805
2024
Q1
$2.49M Sell
50,302
-272,279
-84% -$13M 0.04% 322
2023
Q4
$13.5M Sell
322,581
-140,678
-30% -$4.79M 0.23% 83
2023
Q3
$15.2M Buy
463,259
+129,973
+39% +$4.43M 0.34% 80
2023
Q2
$11.8M Buy
+333,286
New +$11M 0.21% 133
2022
Q4
Sell
-97,143
Closed -$4.03M 1297
2022
Q3
$4.03M Sell
97,143
-59,857
-38% -$2.39M 0.05% 545
2022
Q2
$5.13M Buy
+157,000
New +$5.71M 0.06% 452

Other funds holding PRCT

Polar Asset Management Partners's PRCT Position: Q2 2025 in Review

Polar Asset Management Partners sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 71,980 shares — an estimated $4.19M sold.

Polar Asset Management Partners first reported a position in PRCT in Q2 2022 and held it in 7 quarters. The position peaked at $15.2M in Q3 2023. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • Polar Asset Management Partners reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 71,980 Procept Biorobotics shares in Q2 2025, an estimated $4.19M.
  • Polar Asset Management Partners first reported a position in Procept Biorobotics in Q2 2022 and held it in 7 quarters.
  • Polar Asset Management Partners's Procept Biorobotics position peaked at $15.2M in Q3 2023.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on Polar Asset Management Partners's 13F filing for Q2 2025, filed 14 Aug 2025.